-
Miltefosine, sold
under the
trade name
Impavido among others, is a
medication mainly used to
treat leishmaniasis and free-living
amoeba infections such...
- no data on how well
miltefosine is able to
reach the
central nervous system. As of 2015[update] the U.S. CDC
offered miltefosine to
doctors for the treatment...
- sulfadiazine, azithromycin/clarithromycin, fluconazole, flucytosine, and
miltefosine) but
progressed negatively.
Therefore with the
permission of the FDA...
-
discontinued due to the
emergence of
antifungals with
fewer side
effects Miltefosine works by
damaging fungal cell
membranes Nikkomycin –
blocks formation...
-
amphotericin B, a
combination of
pentavalent antimonials and paromomycin, and
miltefosine. For
cutaneous disease, paromomycin, fluconazole, or
pentamidine may...
-
neoplastic growth with
necrosing portions.
There is a weak
evidence that 6%
miltefosine solution applied topically on
superficial fungating breast lesion less...
-
alternative therapy and
other drugs are effective.[citation needed]
Miltefosine is the only
available oral
medication available for VL and PKDL. While...
- and its
chronic effect is nephrotoxicity. In 1999, an
anticancer drug
miltefosine was
demonstrated to be
highly effective (95% cure rate)
among Indian...
-
Diseases initiative (DNDi) in 2010.
Miltefosine is the
first oral
treatment for this disease. The cure rate of
miltefosine in
Phase III
clinical trials is...
-
control remain unsolved and
deserve urgent attention.[citation needed]
Miltefosine is the only
available oral
medication available for VL and PKDL. While...